Oral diabetes medication - new guidelines

A pair of plain-language guides that outline the latest scientific evidence on the effectiveness and safety of oral medications for adults with type 2 diabetes are now available from HHS' Agency for Healthcare Research and Quality.

AHRQ's analysis is the first to summarize evidence on the effectiveness and adverse events for all commonly used type 2 diabetes medications. As new classes of oral diabetes medications have become available, patients and clinicians have faced a growing list of treatment options and choices. The guides for consumers and clinicians are tools to help patients, their families, and health care providers make informed decisions about treating a condition that affects more than 15 million Americans.

The consumer-targeted guide, called Pills for Type 2 Diabetes: A Guide for Adults (http://effectivehealthcare.ahrq.gov/reports/topic.cfm?topic=5&sid=37&rType=1&sType=1), includes information on:

Types of diabetes pills commonly available for adults

  • How well they work
  • Possible side effects
  • Medication costs

The clinician's guide, called Comparing Oral Medications for Adults With Type 2 Diabetes (http://effectivehealthcare.ahrq.gov/reports/topic.cfm?topic=5&sid=37&rType=9&sType=1), includes more detail on those topics and “confidence ratings” for evidence to support research conclusions.

Type 2 diabetes is an increasingly common chronic disease that occurs in people who have too much glucose in their blood either because their cells are resistant to insulin (a hormone that helps convert glucose into energy) or because their pancreas does not produce enough insulin. Excessive glucose levels can cause severe problems with the heart, eyes, kidneys and nerves. Obesity increases the risk of developing diabetes.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Global diabetes cases exceed 800 million highlighting urgent need for action